首页 > 市场调查报告书 > 医疗设备

医学影像诊断超音波

市场调查报告书

商品编码

1774955

全球血管支架市场

Intravascular Stents

出版日期: 2025年07月23日 | 出版商:

Global Industry Analysts, Inc. | 英文 462 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球血管内支架市场规模将达到 408 亿美元

全球血管支架市场规模预计在2024年为280亿美元，预计到2030年将达到408亿美元，在分析期间（2024-2030年）的复合年增长率为6.5%。药物释放型支架是本报告分析的细分市场之一，预计其复合年增长率为6.6%，到分析期结束时规模将达到265亿美元。裸金属支架市场在分析期间的复合年增长率预计为6.4%。

美国市场规模估计为 76 亿美元，中国市场预计复合年增长率为 10.2%

预计到2024年，美国血管内支架市场规模将达76亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到84亿美元，在2024-2030年的分析期间内，复合年增长率为10.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.2%和6.3%。在欧洲，预计德国市场的复合年增长率为4.3%。

全球血管内支架市场－主要趋势与驱动因素摘要

为什么血管内支架对于心血管治疗的发展至关重要？

血管内支架已成为冠状动脉疾病 (CAD) 和周边血管疾病治疗的基石，为外科手术提供了微创的替代方案。这些小型网状管状装置用于支撑血管并在血管成形术后维持动脉通畅性。心血管疾病仍然是全球最大的死亡原因，对有效且持久治疗方案的需求正在推动血管内支架市场的扩张。技术创新、文明病的日益普及以及週边和神经血管适应症的扩大是推动该市场成长的关键因素。

一个关键趋势是从裸金属支架 (BMS) 转向药物释放型支架 (DES) 和生物可吸收支架 (BRS) 的转变。 DES 可释放抗增生药物以防止血管再阻塞，由于其支架内血管再阻塞发生率较低且长期疗效较佳，正在取代 BMS。生物可吸收支架虽然仍处于应用的早期阶段，但它代表着下一代血管介入技术，因为它提供了一个可随时间溶解的临时支架。此外，支架输送系统、涂层技术和个人化支架尺寸的进步提高了手术成功率，并扩大了其在更广泛血管疾病中的应用。

材料和设计的创新如何改善临床结果？

材料科学和器械工程的快速发展推动了血管内支架的演变。钴铬合金和铂铬合金在支架结构中的应用提高了径向强度、成像可视性和柔韧性，使其成为在曲折血管解剖结构中导航的关键材料。这些材料还能使支架更纤细，减少血管创伤并促进内皮癒合。同时，新一代药物洗脱支架 (DES) 平台采用生物可吸收聚合物涂层，该涂层在药物释放后可降解，从而最大限度地降低了永久性聚合物相关的长期发炎和血栓形成风险。

在神经血管和周边血管市场，由镍钛合金（一种镍钛合金）製成的自动扩张型支架因其超弹性和对血管动力学的适应能力而日益普及。此外，血管内超音波(IVUS) 和光同调断层扫瞄(OCT) 等影像技术的整合正在提高支架置入的准确性，并确保最佳的放置和扩张效果。基于奈米技术的涂层和基因洗脱支架的研究也在进行中，旨在提高药物传输效率并解决诸如晚期支架血栓症等限制。这些进步正在重新定义微创血管治疗的可能性。

哪些治疗领域和使用案例正在推动采用？

冠状动脉疾病仍然是血管内支架应用的最大领域，占全球支架植入手术的绝大部分。缺血性心臟疾病的流行，加上糖尿病、肥胖和高血压盛行率的上升，正在推动已开发市场和新兴市场的治疗量成长。由于支架平台更灵活且易于输送，血管内支架在复杂病变（例如分叉病变、慢性完全闭塞病变和长瀰漫性病变）的应用日益广泛。这些创新使介入性心臟病专家能够将治疗范围扩大到先前不适合植入支架的高风险病患小组。

除了冠状动脉应用外，周边动脉疾病(PAD) 也日益受到关注，尤其是在老年患者群体中。自动扩张型支架广泛应用于股腘动脉和髂动脉，为承受巨大动态压力的血管提供长期通畅性。神经血管支架在脑动脉瘤和缺血性中风的治疗中也得到越来越广泛的应用，尤其是与血栓切除装置合併使用。冠状动脉、週边动脉和神经血管领域使用案例的扩展不仅扩大了潜在市场，也推动了针对不同血管环境专门设计的支架的需求。

从临床、技术和地理角度来看，推动市场成长的因素是什么？

血管内支架市场的成长受到多种因素的驱动，这些因素与临床需求、创新管道以及不断扩展的医疗基础设施有关。其中一个最重要的驱动因素是全球人口老化以及由此导致的心血管和周边血管疾病发病率的上升。这些人口结构变化正在创造对支架等微创高效治疗方案的持续需求，尤其是在门诊病人和门诊环境中。同时，全球医疗保健产业正在转向基于价值的医疗服务，青睐那些能够最大程度缩短住院时间、降低併发症发生率并改善长期疗效的治疗治疗方法。

另一个关键成长要素是医疗设备製造商对下一代支架平台的持续研发投入。专注于药物释放型技术、生物可吸收材料以及整合人工智慧的支架规划工具，正在推动其在竞争激烈的市场中实现差异化。此外，亚太、拉丁美洲和中东地区医疗保健管道和导管室的快速扩张，也促进了手术量的增加。报销制度的改善、有利的临床指南以及医生培训计划也进一步推动了这些地区的应用。临床、技术和结构驱动因素的融合，为全球血管内支架市场的持续强劲成长奠定了基础。

部分

类型（药物释放型、裸金属、生物可吸收）、输送方式（自膨胀、球囊扩张型）、产品类型（冠状动脉、週边、神经血管）、最终用户（医院/心臟中心、门诊手术中心、其他）

受访公司范例

Abbott Laboratories
Alvimedica
Asahi Intecc Co., Ltd.
B. Braun Melsungen AG
Biosensors International Group
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
CR Bard（now part of BD）
Cardinal Health（Cordis）
Cook Medical
Johnson & Johnson
Medinol Ltd.
Medtronic plc
MicroPort Scientific Corporation
Nipro Corporation
OrbusNeich Medical
STENTYS SA
Terumo Corporation
Terumo Interventional Systems

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for Intravascular Stents estimated at US$28.0 Billion in the year 2024, is expected to reach US$40.8 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$26.5 Billion by the end of the analysis period. Growth in the Bare Metal Stents segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 10.2% CAGR

The Intravascular Stents market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.4 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Intravascular Stents Market - Key Trends & Drivers Summarized

Why Are Intravascular Stents Central to the Evolution of Cardiovascular Treatment?

Intravascular stents have become a cornerstone in the management of coronary artery disease (CAD) and peripheral vascular disorders, offering a minimally invasive alternative to surgical interventions. These small mesh-like tubular devices are used to support blood vessels and maintain arterial patency after angioplasty procedures. With cardiovascular diseases remaining the leading cause of death globally, the demand for effective and durable treatment options is driving the expansion of the intravascular stents market. Technological innovation, growing prevalence of lifestyle diseases, and expanded indications in peripheral and neurovascular applications are among the key contributors to market growth.

A significant trend is the transition from bare-metal stents (BMS) to drug-eluting stents (DES) and bioresorbable scaffolds (BRS). DES, which release antiproliferative drugs to prevent restenosis, have largely replaced BMS due to their lower rate of in-stent restenosis and improved long-term outcomes. Bioresorbable stents, although still in early phases of adoption, represent the next generation of vascular intervention technologies by offering temporary scaffolding that dissolves over time. Additionally, advancements in stent delivery systems, coating technologies, and personalized stent sizing are improving procedural success rates and expanding usage across a broader range of vascular conditions.

How Are Innovations in Materials and Design Elevating Clinical Outcomes?

The evolution of intravascular stents is being driven by rapid progress in materials science and device engineering. The use of cobalt-chromium and platinum-chromium alloys in stent construction has enhanced radial strength, visibility under imaging, and flexibility-critical for navigating tortuous vascular anatomies. These materials also allow thinner struts, which reduce vessel trauma and promote faster endothelial healing. In parallel, new-generation DES platforms feature bioabsorbable polymer coatings that degrade after drug release, minimizing long-term inflammation and thrombogenic risk associated with permanent polymers.

In neurovascular and peripheral vascular markets, self-expanding stents made of nitinol (nickel-titanium alloy) are gaining traction due to their superelastic properties and ability to adapt to vessel dynamics. Moreover, the integration of imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) is enhancing stent placement accuracy, ensuring optimal apposition and expansion. Research into nanotechnology-based coatings and gene-eluting stents is also underway, aiming to improve drug delivery efficiency and address limitations like late stent thrombosis. These advances are redefining what’s possible in minimally invasive vascular therapy.

Which Therapeutic Segments and Use Cases Are Driving Adoption?

Coronary artery disease remains the largest segment for intravascular stent use, accounting for the bulk of global procedures. The widespread prevalence of ischemic heart disease, combined with the rising incidence of diabetes, obesity, and hypertension, is fueling procedural volumes in both developed and emerging markets. Intravascular stents are increasingly being used in complex lesions, such as bifurcations, chronic total occlusions, and long diffuse lesions, thanks to more flexible and deliverable stent platforms. These innovations allow interventional cardiologists to expand treatment to high-risk patient groups that were previously unsuitable for stenting.

Beyond coronary applications, peripheral artery disease (PAD) is a growing area of focus, particularly in aging populations. Self-expanding stents are widely used in the femoropopliteal and iliac arteries, providing long-term patency in vessels subject to high biomechanical stress. Neurovascular stents are also seeing increased deployment in the treatment of cerebral aneurysms and ischemic stroke, especially in conjunction with thrombectomy devices. These expanded use cases across coronary, peripheral, and neurovascular domains are not only increasing total addressable market size but also driving demand for specialized stent designs tailored to different vascular environments.

What’s Fueling the Market Growth Across Clinical, Technological, and Regional Dimensions?

The growth in the intravascular stents market is driven by several factors related to clinical demand, innovation pipelines, and expanding healthcare infrastructure. One of the most significant drivers is the aging global population and the associated rise in cardiovascular and peripheral vascular conditions. This demographic shift is creating sustained demand for less invasive, high-efficacy treatment solutions like stents, particularly in outpatient and ambulatory care settings. Concurrently, the global healthcare industry is moving toward value-based care, favoring interventions that minimize hospital stays, reduce complication rates, and improve long-term outcomes-attributes that intravascular stents are well-positioned to deliver.

Another key growth factor is the ongoing R&D investment by medical device companies in next-generation stent platforms. The focus on drug-eluting technology, bioresorbable materials, and AI-integrated stent planning tools is fostering differentiation in an otherwise competitive market. Additionally, the rapid expansion of healthcare access and catheterization labs in Asia-Pacific, Latin America, and the Middle East is contributing to higher procedural volumes. Reimbursement improvements, favorable clinical guidelines, and physician training programs are further supporting adoption in these regions. The convergence of these clinical, technological, and structural drivers is setting the stage for sustained and robust growth in the global intravascular stents market.

SCOPE OF STUDY:

The report analyzes the Intravascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents); Delivery Mode (Self-expanding Stents, Balloon-expandable Stents); Product Type (Coronary Stents, Peripheral Stents, Neurovascular Stents); End-Use (Hospitals & Cardiac Centers, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

Abbott Laboratories
Alvimedica
Asahi Intecc Co., Ltd.
B. Braun Melsungen AG
Biosensors International Group
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
C. R. Bard (now part of BD)
Cardinal Health (Cordis)
Cook Medical
Johnson & Johnson
Medinol Ltd.
Medtronic plc
MicroPort Scientific Corporation
Nipro Corporation
OrbusNeich Medical
STENTYS SA
Terumo Corporation
Terumo Interventional Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Intravascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Global Burden of Cardiovascular Diseases Drives Demand for Intravascular Stents
- Growing Aging Population With High Risk of Atherosclerosis Expands Stent Implantation Procedures
- Technological Advancements in Drug-Eluting Stents (DES) Propel Market Differentiation and Outcomes
- Expansion of Peripheral Artery Disease Treatment Strengthens Demand for Non-Coronary Stent Solutions
- Rising Preference for Minimally Invasive Angioplasty Procedures Fuels Adoption of Stents
- Increasing Use of Bioresorbable and Polymer-Free Stents Creates Product Innovation Opportunities
- Growing Clinical Evidence Supporting Long-Term Outcomes of Newer-Generation Stents Enhances Physician Confidence
- Development of Hybrid and Dual Therapy Stents Targets Complex Lesion Management
- Integration of Advanced Imaging (IVUS, OCT) With PCI Procedures Drives Accurate Stent Placement
- Expansion of Interventional Cardiology Programs in Emerging Markets Unlocks New Patient Segments
- Surge in Transradial Access Procedures Enhances Demand for Deliverable, Flexible Stent Designs
- Rising Prevalence of Diabetes and Comorbidities Fuels Need for Advanced Coated and Customized Stents
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Intravascular Stents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Intravascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Bare Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Bioabsorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Bioabsorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Bioabsorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Self-expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Self-expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Self-expanding Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: World 15-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 38: USA Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: USA 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: USA 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Canada 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Canada 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 59: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Canada Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Canada 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
JAPAN
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Japan 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 68: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Japan Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Japan 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 71: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Japan Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: Japan 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
CHINA
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: China 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 77: China Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: China Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: China 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 80: China Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: China Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: China 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 83: China Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: China Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: China 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
EUROPE
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Intravascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Europe 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 89: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Europe Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Europe 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 92: Europe Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Europe Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: Europe 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 95: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: Europe Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: Europe 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 98: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Europe Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: Europe 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
FRANCE
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 101: France Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: France Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: France 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 104: France Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: France Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: France 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 107: France Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: France Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: France 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 110: France Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: France Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: France 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
GERMANY
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 113: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: Germany Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 115: Germany 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 116: Germany Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: Germany Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 118: Germany 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 119: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: Germany Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 121: Germany 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 122: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: Germany Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 124: Germany 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
ITALY
- TABLE 125: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Italy Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 127: Italy 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 128: Italy Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Italy Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 130: Italy 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 131: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Italy Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 133: Italy 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 134: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Italy Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 136: Italy 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
UNITED KINGDOM
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 137: UK Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: UK Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 139: UK 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 140: UK Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: UK Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 142: UK 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 143: UK Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: UK Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 145: UK 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 146: UK Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: UK Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 148: UK 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
SPAIN
- TABLE 149: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Spain Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 151: Spain 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 152: Spain Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Spain Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 154: Spain 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 155: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Spain Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 157: Spain 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 158: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Spain Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 160: Spain 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 161: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Russia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 163: Russia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 164: Russia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Russia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 166: Russia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 167: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Russia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 169: Russia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 170: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Russia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 172: Russia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: Rest of Europe Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 175: Rest of Europe 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: Rest of Europe Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 178: Rest of Europe 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: Rest of Europe Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 181: Rest of Europe 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: Rest of Europe Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 184: Rest of Europe 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 186: Asia-Pacific Historic Review for Intravascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 187: Asia-Pacific 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: Asia-Pacific Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 190: Asia-Pacific 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Asia-Pacific Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 193: Asia-Pacific 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Asia-Pacific Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 196: Asia-Pacific 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Asia-Pacific Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 199: Asia-Pacific 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
AUSTRALIA
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 200: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Australia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 202: Australia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 203: Australia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Australia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 205: Australia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 206: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Australia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 208: Australia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 209: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Australia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 211: Australia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
INDIA
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 212: India Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: India Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 214: India 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 215: India Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: India Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 217: India 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 218: India Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: India Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 220: India 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 221: India Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: India Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 223: India 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 224: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: South Korea Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 226: South Korea 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 227: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: South Korea Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 229: South Korea 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 230: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: South Korea Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 232: South Korea 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 233: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: South Korea Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 235: South Korea 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Asia-Pacific Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Asia-Pacific Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Asia-Pacific Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Asia-Pacific Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
LATIN AMERICA
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 248: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 249: Latin America Historic Review for Intravascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 250: Latin America 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 251: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Latin America Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 253: Latin America 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 254: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Latin America Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 256: Latin America 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 257: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Latin America Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 259: Latin America 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 260: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Latin America Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 262: Latin America 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 263: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Argentina Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 265: Argentina 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 266: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Argentina Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 268: Argentina 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 269: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Argentina Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 271: Argentina 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 272: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Argentina Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 274: Argentina 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 275: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Brazil Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 277: Brazil 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 278: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Brazil Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 280: Brazil 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 281: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Brazil Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 283: Brazil 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 284: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: Brazil Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 286: Brazil 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
MEXICO
- TABLE 287: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: Mexico Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 289: Mexico 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 290: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: Mexico Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 292: Mexico 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 293: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: Mexico Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 295: Mexico 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 296: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Mexico Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 298: Mexico 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Latin America Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 301: Rest of Latin America 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Latin America Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 304: Rest of Latin America 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Rest of Latin America Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 307: Rest of Latin America 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Rest of Latin America Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 310: Rest of Latin America 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
MIDDLE EAST
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 311: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 312: Middle East Historic Review for Intravascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 313: Middle East 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 314: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 315: Middle East Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 316: Middle East 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 317: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 318: Middle East Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 319: Middle East 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 320: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 321: Middle East Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 322: Middle East 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 323: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 324: Middle East Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 325: Middle East 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
IRAN
- TABLE 326: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 327: Iran Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 328: Iran 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 329: Iran Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 330: Iran Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 331: Iran 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 332: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 333: Iran Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 334: Iran 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 335: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 336: Iran Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 337: Iran 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
ISRAEL
- TABLE 338: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 339: Israel Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 340: Israel 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 341: Israel Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 342: Israel Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 343: Israel 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 344: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 345: Israel Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 346: Israel 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 347: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 348: Israel Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 349: Israel 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
SAUDI ARABIA
- TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 351: Saudi Arabia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 352: Saudi Arabia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 354: Saudi Arabia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 355: Saudi Arabia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 357: Saudi Arabia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 358: Saudi Arabia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 360: Saudi Arabia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 361: Saudi Arabia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 362: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 363: UAE Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 364: UAE 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 365: UAE Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 366: UAE Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 367: UAE 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 368: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 369: UAE Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 370: UAE 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 371: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 372: UAE Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 373: UAE 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 375: Rest of Middle East Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 376: Rest of Middle East 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 378: Rest of Middle East Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 379: Rest of Middle East 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 381: Rest of Middle East Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 382: Rest of Middle East 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 384: Rest of Middle East Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 385: Rest of Middle East 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
AFRICA
- Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 386: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 387: Africa Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 388: Africa 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
- TABLE 389: Africa Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 390: Africa Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 391: Africa 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
- TABLE 392: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 393: Africa Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 394: Africa 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
- TABLE 395: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 396: Africa Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 397: Africa 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030